Melanoma's deadly march to the brain: by what route, and can it be stopped?

Free article

Editorial

Megan Othus et al. Cancer. 2011.

Free article

. 2011 Apr 15;117(8):1560-3.

doi: 10.1002/cncr.25716. Epub 2010 Nov 10.

No abstract available

Comment on

Prognostic factors for survival in melanoma patients with brain metastases.
Davies MA, Liu P, McIntyre S, Kim KB, Papadopoulos N, Hwu WJ, Hwu P, Bedikian A. Davies MA, et al. Cancer. 2011 Apr 15;117(8):1687-96. doi: 10.1002/cncr.25634. Epub 2010 Oct 19. Cancer. 2011. PMID: 20960525
Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma.
Eigentler TK, Figl A, Krex D, Mohr P, Mauch C, Rass K, Bostroem A, Heese O, Koelbl O, Garbe C, Schadendorf D; Dermatologic Cooperative Oncology Group and the National Interdisciplinary Working Group on Melanoma. Eigentler TK, et al. Cancer. 2011 Apr 15;117(8):1697-703. doi: 10.1002/cncr.25631. Epub 2010 Nov 8. Cancer. 2011. PMID: 21472716
Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survival.
Zakrzewski J, Geraghty LN, Rose AE, Christos PJ, Mazumdar M, Polsky D, Shapiro R, Berman R, Darvishian F, Hernando E, Pavlick A, Osman I. Zakrzewski J, et al. Cancer. 2011 Apr 15;117(8):1711-20. doi: 10.1002/cncr.25643. Epub 2010 Nov 8. Cancer. 2011. PMID: 21472718 Free PMC article.